Shandong Weigao Group Medical Polymer - SHWGF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.67
+0 (0.00%)

This chart shows the closing price for SHWGF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Shandong Weigao Group Medical Polymer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SHWGF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SHWGF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Shandong Weigao Group Medical Polymer in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.67.

This chart shows the closing price for SHWGF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Shandong Weigao Group Medical Polymer. This rating has held steady since April 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/2/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/29/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/28/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/22/2023The Goldman Sachs GroupUpgradeNeutral ➝ Buy
(Data available from 12/23/2019 forward)

News Sentiment Rating

0.30 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/25/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/24/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/23/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/23/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Shandong Weigao Group Medical Polymer logo
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables. It also provides tumour and blood vessel interventional instruments; flushing syringes; blood collection, irradiation, storage, separation and sterilization products; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture Instruments; medicines; and X-ray based irradiation machines. In addition, it is involved in the finance leasing and factoring business; provision of enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
Read More

Today's Range

Now: $0.67
Low: $0.67
High: $0.67

50 Day Range

MA: $0.74
Low: $0.67
High: $0.96

52 Week Range

Now: $0.67
Low: $0.67
High: $0.67

Volume

N/A

Average Volume

5,200 shs

Market Capitalization

$3.01 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.2

Frequently Asked Questions

What sell-side analysts currently cover shares of Shandong Weigao Group Medical Polymer?

The following Wall Street research analysts have issued stock ratings on Shandong Weigao Group Medical Polymer in the last year:
View the latest analyst ratings for SHWGF.

What is the current price target for Shandong Weigao Group Medical Polymer?

0 Wall Street analysts have set twelve-month price targets for Shandong Weigao Group Medical Polymer in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Shandong Weigao Group Medical Polymer in the next year.
View the latest price targets for SHWGF.

What is the current consensus analyst rating for Shandong Weigao Group Medical Polymer?

Shandong Weigao Group Medical Polymer currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SHWGF.

What other companies compete with Shandong Weigao Group Medical Polymer?

Other companies that are similar to Shandong Weigao Group Medical Polymer include Smith & Nephew, Demant A/S, MSA Safety, Enovis and Cadre. Learn More about companies similar to Shandong Weigao Group Medical Polymer.

How do I contact Shandong Weigao Group Medical Polymer's investor relations team?

Shandong Weigao Group Medical Polymer's physical mailing address is 18 Xing Shan Road Torch Hi-Tech Science Park, Weihai F4, 264210. The company's listed phone number is 0631-5621999 and its investor relations email address is [email protected]. The official website for Shandong Weigao Group Medical Polymer is www.weigaogroup.com. Learn More about contacing Shandong Weigao Group Medical Polymer investor relations.